HPLC Purity
HPLC purity of a peptide is the central quality indicator used by suppliers and control laboratories. It corresponds to the percentage of the main peak area over the sum of all detected peak areas in an HPLC chromatogram at a given wavelength. It is a relative, not absolute, measure: it does not account for impurities that do not absorb at the analysis wavelength nor for residual salts and solvents.
The calculation principle is simple: HPLC purity (%) = (main peak area / sum of all peak areas) × 100. A peptide at 98 % HPLC purity therefore contains 98 % of the target species and 2 % of impurities detectable at the analysis wavelength, distributed in one or more secondary peaks.
Standard instrumentation pairs a C18 reverse-phase chromatographic column (typical: 4.6 × 150 mm or 2.1 × 100 mm, 3 to 5 μm particles), an acetonitrile/water gradient mobile phase with 0.1 % trifluoroacetic acid (TFA) or 0.1 % formic acid, and a diode array UV detector monitoring 220 nm (amide bond) and 280 nm (tyrosine, tryptophan). A 0.5 to 1 mL/min flow rate and a 10 to 30 minute analysis time suffice to separate most peptides.
Acceptance thresholds vary with use. In preclinical in vitro research, convention accepts ≥ 95 % for most assays, ≥ 98 % for fine quantitative assays (binding, enzymology, pharmacokinetics). In pharmaceutical development, regulatory authorities require ≥ 98 % with exhaustive characterization of any impurity > 0.1 % (MS identification, origin, toxicological profile). USP and Ph. Eur. pharmacopoeias detail criteria by monograph.
Interpreting an HPLC chromatogram involves several checks. First, the main peak must be symmetric (symmetry factor As between 0.9 and 1.5); peak tailing indicates secondary column interaction or degradation. Second, resolution between the main peak and neighboring impurities must be sufficient (Rs > 1.5) to allow reliable integration. Third, secondary peaks must be annotated: peak numbers, retention times, relative percentages. Fourth, the baseline must be stable and without significant drift.
Typical SPPS peptide impurities appear in order: truncated peptides (missing one or more residues, earlier elution for shorter ones), peptides with oxidized amino acids (Met sulfoxide, more polar and therefore earlier elution), deamidated peptides (Asn→Asp + iso-Asp, often two close peaks), racemized peptides (D-isomer, sometimes imperfect co-elution), disulfide dimers. Well-conducted HPLC analysis identifies each of these peaks by coupled MS for a complete quality control dossier.
For a research peptide user, requiring a readable HPLC chromatogram (main peak, retention time, percentage), accompanied by a mass spectrometry confirming identity, is the minimum to guarantee batch quality.